TY - JOUR
T1 - An increase in exhaled CO concentration in systemic inflammation/sepsis
AU - Morimatsu, Hiroshi
AU - Takahashi, Toru
AU - Matsusaki, Takashi
AU - Hayashi, Masao
AU - Matsumi, Jyunya
AU - Shimizu, Hiroko
AU - Matsumi, Masaki
AU - Morita, Kiyoshi
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/12
Y1 - 2010/12
N2 - Despite recent progress in Critical Care Medicine, sepsis is still a major medical problem with a high rate of mortality and morbidity especially in intensive care units. Oxidative stress induced by inflammation associated with sepsis causes degradation of heme protein, increases microsomal free heme content, promotes further oxidative stress and results in cellular and organ damage. Heme-oxygenase-1 (HO-1) is a rate-limiting enzyme for heme breakdown. HO-1 breaks down heme to yield CO, iron and biliverdin. Measurement of CO in exhaled air may potentially be useful in monitoring changes in HO enzyme activity in vivo, which might reflect the degree of inflammation or oxidative stress in patients with systemic inflammation. The increased exhaled CO concentrations were observed after anesthesia/surgery, in critically ill patients and also in systemic inflammation/sepsis. Some reports also showed that exhaled CO concentration is related to mortality. Further studies are needed to elucidate whether increased endogenous CO production may predict a patient's morbidity and mortality. Techniques for monitoring CO are continuously being refined and this technique may find its way into the office of clinicians.
AB - Despite recent progress in Critical Care Medicine, sepsis is still a major medical problem with a high rate of mortality and morbidity especially in intensive care units. Oxidative stress induced by inflammation associated with sepsis causes degradation of heme protein, increases microsomal free heme content, promotes further oxidative stress and results in cellular and organ damage. Heme-oxygenase-1 (HO-1) is a rate-limiting enzyme for heme breakdown. HO-1 breaks down heme to yield CO, iron and biliverdin. Measurement of CO in exhaled air may potentially be useful in monitoring changes in HO enzyme activity in vivo, which might reflect the degree of inflammation or oxidative stress in patients with systemic inflammation. The increased exhaled CO concentrations were observed after anesthesia/surgery, in critically ill patients and also in systemic inflammation/sepsis. Some reports also showed that exhaled CO concentration is related to mortality. Further studies are needed to elucidate whether increased endogenous CO production may predict a patient's morbidity and mortality. Techniques for monitoring CO are continuously being refined and this technique may find its way into the office of clinicians.
UR - http://www.scopus.com/inward/record.url?scp=78649896952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649896952&partnerID=8YFLogxK
U2 - 10.1088/1752-7155/4/4/047103
DO - 10.1088/1752-7155/4/4/047103
M3 - Short survey
C2 - 21383490
AN - SCOPUS:78649896952
SN - 1752-7155
VL - 4
JO - Journal of Breath Research
JF - Journal of Breath Research
IS - 4
M1 - 47103
ER -